Papaconstantinou Dimitris, Georgalas Ilias, Karmiris Themis, Ladas Ioannis, Droutsas Konstantinos, Georgopoulos Gerasimos
Department of Ophthalmology, "G, Gennimatas" Hospital, University of Athens, Greece.
J Med Case Rep. 2010 Jun 30;4:203. doi: 10.1186/1752-1947-4-203.
We report a case of early lactobacillus endophthalmitis which occurred ten days after trabeculectomy.
A 76-year-old Caucasian diabetic woman underwent uncomplicated trabeculectomy with a collagen implant as an adjunct, in her left phakic eye, for the treatment of uncontrolled open-angle glaucoma. Ten days post-operatively, our patient complained of left phakic eye discharge pain and visual acuity decreased to "light-perception". The anterior chamber had 3+ cells and flare, and there was also 2 mm layered hypopyon. Vitreous involvement was present obscuring visualization of the fundus. On the same day our patient underwent vitrectomy surgery and intra-vitreal and systemic antibiotics were administered. Vitreous cultures grew Lactobacillus brevis. Our patient responded well to treatment and 30 days after vitrectomy visual acuity improved to 1/10. Six months later our patient underwent cataract surgery. Eight months after initial surgery visual acuity was 2/10 and intra-ocular pressure was 14 mmHg without any anti-glaucoma medication.
This is the first report of acute lactobacillus endophthalmitis in the phakic eye of a diabetic patient after trabeculectomy. Glaucoma surgeons should be aware of the potential for acute post-operative endophthalmitis due to rare microorganisms, such as lactobacillus, in glaucoma filtration surgery, especially in diabetic patients. The literature shows an increased risk of endophthalmitis when anti-metabolites are used in conjunction with trabeculectomy. Perhaps, any type of wound healing modulation, such as collagen or mitomycin-C may increase this risk. However, it is unclear at this time and more studies need to be done. In this single case, vitrectomy combined with intra-vitreal and systemic antibiotics were efficient in limiting the devastating sequels of this complication.
我们报告一例小梁切除术后10天发生的早期乳酸杆菌性眼内炎病例。
一名76岁的白种糖尿病女性,其左眼有晶状体,因治疗控制不佳的开角型青光眼,接受了单纯小梁切除术,并植入胶原植入物作为辅助治疗。术后10天,患者主诉左眼有晶状体眼出现分泌物、疼痛,视力降至“光感”。前房有3+细胞和闪光,还有2mm的分层积脓。存在玻璃体受累,眼底无法看清。同一天,患者接受了玻璃体切除术,并给予玻璃体内和全身抗生素治疗。玻璃体培养物培养出短乳杆菌。患者对治疗反应良好,玻璃体切除术后30天视力提高到1/10。6个月后患者接受了白内障手术。初次手术后8个月,视力为2/10,眼压为14mmHg,未使用任何抗青光眼药物。
这是首例糖尿病患者小梁切除术后有晶状体眼发生急性乳酸杆菌性眼内炎的报告。青光眼外科医生应意识到,在青光眼滤过手术中,尤其是糖尿病患者,罕见微生物如乳酸杆菌可能导致急性术后眼内炎。文献表明,小梁切除术联合使用抗代谢药物时眼内炎风险增加。也许,任何类型的伤口愈合调节,如胶原或丝裂霉素-C,都可能增加这种风险。然而,目前尚不清楚,需要进行更多研究。在这例单一病例中,玻璃体切除术联合玻璃体内和全身抗生素治疗有效地限制了该并发症的严重后果。